Skip to main content
. Author manuscript; available in PMC: 2017 Feb 9.
Published in final edited form as: Complexity. 2015 Dec 23;21(Suppl 1):291–306. doi: 10.1002/cplx.21743

TABLE 3.

Allostatic Load Clusters and Their Differences on Key Self-Reported Health Measures

Clustera
Health Assessmentb 1 2 3 4 5 6 7 8 9
Low
Cholesterol
Healthy
High BP
Low Stress
Hormone
Metabolic
Syndrome
Hi Blood
Sugar
Low Stress
Antagonist
High Stress
Hormone
High Pro-
Inflammatory
Yes No Yes No Yes No Yes No Yes No Yes No Yes No Yes No Yes No
Heart disease Observedc 15 81 1 137 10 145 12 157 7 136 8 26 24 85 26 119 27 75
Expected 11.40 84.60 16.40 121.60 18.50 136.50 20.10 148.90 17 126.00 4.10 29.90 13.00 96.00 17.30 127.70 12.20 89.80
High blood pressure Observed 29 63 8 129 49 102 58 110 61 81 15 20 51 55 63 82 61 42
Expected 33.89 58.68 49.92 86.45 55.75 96.54 61.22 106.01 52.47 90.86 12.75 22.08 38.63 66.89 52.84 91.49 37.53 64.99
Circulation problems Observed 9 86 9 128 12 139 10 157 16 128 7 28 15 93 11 130 20 78
Expected 9.61 85.30 13.87 123.01 15.38 136.48 16.90 149.94 14.57 129.29 3.54 31.43 10.93 96.97 14.27 126.60 9.92 87.99
blood clots Observed 5 91 4 134 4 151 11 157 5 139 4 31 6 102 9 137 13 91
Expected 5.35 90.65 7.69 130.31 8.64 146.36 9.37 158.63 8.03 135.97 1.95 33.05 6.02 101.98 8.14 137.86 5.80 98.20
Heart murmur Observed 12 83 14 124 17 138 28 139 19 124 4 31 16 90 28 116 18 85
Expected 13.63 81.28 19.80 118.07 22.24 132.61 24.11 143.74 20.52 122.35 5.02 29.94 15.21 90.69 20.67 123.20 14.78 88.12
TIA/stroke Observed 6 90 2 136 6 149 2 165 4 139 2 33 6 101 8 138 7 97
Expected 3.78 92.13 5.43 132.44 6.10 148.75 6.58 160.27 5.67 138.20 1.38 33.59 4.21 102.69 5.75 140.12 4.10 99.81
Anemia Observed 17 79 27 110 13 142 36 133 13 130 4 31 26 83 11 135 16 87
Expected 14.32 81.68 20.43 116.57 23.12 131.88 25.20 143.80 21.33 121.67 5.22 29.78 16.26 92.74 21.77 124.20 15.36 87.64
Cholesterol problems Observed 42 53 28 110 38 111 79 87 83 57 19 14 49 57 66 78 68 35
Expected 41.52 52.95 60.31 76.92 65.99 84.17 72.99 93.09 61.62 78.59 14.86 18.95 46.76 59.64 62.93 80.27 45.01 57.41
Diabetes Observed 2 93 4 134 6 149 10 159 11 133 28 7 6 103.0 19 126 37 65
Expected 10.68 84.15 15.52 122.23 17.43 137.29 19.00 149.69 16.19 127.55 3.94 31.00 12.26 96.55 16.41 129.32 11.58 91.23
Asthma Observed 13 83 11 127 16 139 18 150 23 121 3 31 16 92 14 130 19 85
Expected 11.69 84.22 16.81 121.07 18.88 135.98 20.58 148.26 17.54 126.33 4.14 29.83 13.15 94.75 17.54 126.33 12.67 91.24
Emphysema/COPD Observed 2 93 5 133 1 154 3 165 2 142 1 34 5 103 4 141 8 96
Expected 2.69 92.22 3.91 133.96 4.40 150.46 4.79 164.05 4.08 139.78 0.99 33.98 3.06 104.84 4.11 140.75 2.95 100.96
Tuberculosis Observed 1 95 2 136 0 155 0 168 1 143 0 35 1 108 0 146 1 103
Expected 0.53 95.47 0.76 137.24 0.85 154.15 0.92 167.08 0.79 143.21 0.19 34.81 0.60 108.40 0.80 145.20 0.57 103.43
Positive TB skin test Observed 5 90 8 130 7 146 11 158 6 137 7 28 13 96 18 126 14 90
Expected 7.76 87.24 11.27 126.73 12.49 140.51 13.80 155.20 11.68 131.32 2.86 32.14 8.90 100.10 11.76 132.24 8.49 95.51
Thyroid disease Observed 14 81 17 121 17 138 25 144 14 130 4 31 22 87 10 135 16 88
Expected 12.19 83.73 17.52 120.36 19.68 135.18 21.45 147.39 18.28 125.59 4.44 30.53 13.84 95.06 18.41 126.46 13.20 90.70
Peptic ulcer Observed 2 93 3 133 5 149 16 151 8 135 0 34 8 101 7 138 7 96
Expected 4.90 90.10 7.01 128.99 7.94 146.06 8.61 158.39 7.37 135.63 1.75 32.25 5.62 103.38 7.48 137.52 5.31 97.69
Cancer Observed 16 80 22 116 10 144 18 151 21 122 4 31 22 87 21 124 23 81
Expected 13.79 82.21 19.82 118.18 22.12 131.88 24.28 144.72 20.54 122.46 5.03 29.97 15.66 93.34 20.83 124.17 14.94 89.06
Colon polyp Observed 18 77 17 121 19 136 35 133 22 121 8 26 31 78 30 115 28 74
Expected 18.13 76.78 26.33 111.54 29.58 125.28 32.25 136.60 27.29 115.58 6.49 27.48 20.80 88.10 27.67 117.20 19.46 82.44
Arthritis Observed 30 61 35 99 59 93 71 94 69 74 17 17 65 38 59 84 56 41
Expected 39.50 51.50 58.17 75.83 65.98 86.02 71.62 93.38 62.07 80.93 14.76 19.24 44.71 58.29 62.07 80.93 42.11 54.89
Glaucoma Observed 3 93 5 133 6 148 8 159 2 142 0 35 7 101 4 141 7 97
Expected 3.69 92.14 5.30 132.44 5.92 147.80 6.46 161.24 5.53 138.20 1.34 33.59 4.15 103.65 5.61 140.12 4.00 99.81
Liver cirrhosis Observed 2 94 1 137 3 152 4 165 3 141 0 35 1 107 3 143 4 99
Expected 1.84 94.16 2.65 135.35 2.98 152.02 3.24 165.76 2.76 141.24 0.67 34.33 2.07 105.93 2.80 143.20 1.98 101.02
Alcoholism Observed 6 90 3 135 9 145 3 166 2 139 0 35 2 106 4 142 3 101
Expected 2.82 93.18 4.05 133.95 4.52 149.48 4.96 164.04 4.14 136.86 1.03 33.97 3.17 104.83 4.28 141.72 3.05 100.95
Depression Observed 24 71 29 105 25 130 50 117 38 105 7 28 30 78 26 118 26 75
Expected 22.39 72.61 31.58 102.42 36.53 118.47 39.36 127.64 33.70 109.30 8.25 26.75 25.45 82.55 33.94 110.06 23.80 77.20
Blood transfusion Observed 7 88 7 128 11 141 20 146 7 134 5 30 19 88 9 136 22 78
Expected 9.45 85.55 13.42 121.58 15.12 136.88 16.51 149.49 14.02 126.98 3.48 31.52 10.64 96.36 14.42 130.58 9.94 90.06
a

Clusters from the nine-cluster solution shown in Table 2.

b

Health Assessments used in StudyÅsee Methods section for more details.

c

Logistic regression was used to test the overall chi-square obtained when testing membership in all clusters. The current table was created for visual inspection of obvious patterns in terms of comparing observed frequency to expected frequency across all nine clusters.